OAC
GSK icon

OMERS Administration Corp’s GSK GSK Stock Holding History

OMERS Administration Corp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-76,100
Closed -$2.95M – 972
2025
Q1 		$2.95M Buy
+76,100
New +$2.79M 0.03% 253
2024
Q3 		– Sell
-29,900
Closed -$1.15M – 969
2024
Q2 		$1.15M Buy
+29,900
New +$1.26M 0.01% 498

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

OMERS Administration Corp's GSK Position: Q2 2025 in Review

OMERS Administration Corp sold out of GSK (GSK) in Q2 2025, closing a stake of 76,100 shares — an estimated $2.95M sold.

OMERS Administration Corp first reported a position in GSK in Q2 2024 and held it in 2 quarters. The position peaked at $2.95M in Q1 2025. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

  • OMERS Administration Corp reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 76,100 GSK shares in Q2 2025, an estimated $2.95M.
  • OMERS Administration Corp first reported a position in GSK in Q2 2024 and held it in 2 quarters.
  • OMERS Administration Corp's GSK position peaked at $2.95M in Q1 2025.
  • 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on OMERS Administration Corp's 13F filing for Q2 2025, filed 13 Aug 2025.